¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-2ÀÏ : 2024-03-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-2ÀÏ : 2024-03-29
±³À°ÀÏÀÚ : 2024-03-29
±³À°Àå¼Ò : ±×·£µå¿öÄ¿ÈúÈ£ÅÚ

±³À°ÁÖÁ¦ : 2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-2ÀÏ

ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581  

À̸ÞÀÏ : hematology@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú

Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 35ºÐ

¼¼ºÎ¼ö°­·á : 300,000¿ø  

ºñ°í 2¿ù 28ÀϱîÁö  ȸ¿ø 100,000¿ø / ºñȸ¿ø 200,000¿ø3¿ù 1ÀϺÎÅÍ    ȸ¿ø  200,000¿ø / ºñȸ¿ø 300,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 09:00~09:25 The impact of immune profiling of T-cell and plasma cells on non-cellular immune therapy in myeloma Nizar J Bahlis(University of Calgary Canada)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 09:25~09:50 Single-cell techniques to characterize immune microenvironment in MM(multiple myeloma) Niels Weinhold(Univ Hosp Heidelberg Gemany)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 09:50~10:15 The power of ONE: Immunology in the age of single cell genomics Ido Amit(Weizmann Institute of Science Israel)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 10:30~11:15 How to win: Competitive strategies in the hematopoietic stem cell niche Margaret Goodell(Baylor College of Medicine USA)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 11:15~12:00 Factors Effect Quality Of Life Childhood Acute Lymphoblastic Leukemia Patients In Indonesia Ferza Alfath(Universitas Andalas Indonesia)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 12:15~13:05 Optimizing tolerability with asciminib in CML patients for better patient outcomes Qian Jiang(Peking University China)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 13:20~14:50 Clinical outcomes of TPO-receptor agonists in patients with steroid-refractory immune thrombocytopenia; Significant conditions of discontinuation with good response Jae-Ho Yoon(The Catholic University of Korea)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM2 15:05~15:30 Palliative care for patients with leukemia Min Sun Kim(Seoul National University Korea)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM2 15:30~15:55 Long-term survivorship in hematologic malignancies Shahrukh K. Hashmi(Mayo Clinic USA)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM2 15:55~16:20 The importance of monitoring symptoms and quality of life in routine hematology practice Fabio Efficace(Italian Group for Adult Hematologic Diseases Italy)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 16:35~17:00 Back to the basic: coagulation pathway Seonyang Park(Inje University Korea)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 17:00~17:25 Pharmacology: Anticoagulants and reversal agents Seo-Yeon Ahn(Chonnam National University Korea)

±³À°½Ã°£ 03¿ù 29ÀÏ ROOM4 17:25~17:50 Proper application of anticoagulation therapy on CAT Ho-Young Yhim(Jeonbuk National University Korea)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-2ÀÏ : 2024-03-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³âµµ ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Ãá°èÇмú´ëȸ : 2024-03-29
´ÙÀ½±Û 2024³â ´ëÇѹé½ÅÇÐȸ Á¦23Â÷ Ãá°èÇмú´ëȸ : 2024-03-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20664 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¼Ò¾Æû¼Ò³â°ú Çù·ÂÀÇ»ç Áý´ãȸ : 2024-05-28 0 28 2024-05-10
20663 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦1ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-05-27 0 26 2024-05-10
20662 ¼­¿ï ´ëÇѿ°èÁٱ⼼Æ÷Àç»ýÀÇÇÐȸ - Á¦20ȸ Ãá°èÇмú´ëȸ (ÇÏÀ̺긮µå) : 2024-05-26 0 18 2024-05-10
20661 ºÎ»ê ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ºÎ¿ï°æÁöȸ 5¿ù ¿¬¼ö°­Á : 2024-05-26 0 15 2024-05-10
20660 ¼­¿ï ´ëÇѽŰæ±Ù°ñ°áÃÊÀ½ÆÄÇÐȸ Á¦1ȸ ÇÚÁî¿Â ¿öÅ©¼ó : 2024-05-25 0 24 2024-05-10
20659 ´ëÀü ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-´ëÀüÃæ³² : 2024-05-25 0 10 2024-05-10
20658 ºÎ»ê ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-25 0 14 2024-05-10
20657 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25 0 14 2024-05-10
20656 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦1Â÷ FLS ÄÚµð³×ÀÌÅÍ ¿öÅ©¼ó : 2024-05-24 0 19 2024-05-10
20655 ¼­¿ï Á¦ 66ȸ Çѱ¹Ç×°ø¿ìÁÖÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-24 0 7 2024-05-10
20654 ´ëÀü °ø°ø±â°ü ÀçÁ÷ÀÇ»ç Ãá°è Çмú´ëȸ (2ÀÏÂ÷) : 2024-05-24 0 12 2024-05-10
20653 ºÎ»ê ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-24 0 14 2024-05-10
20652 ¼­¿ï Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦ 44 Â÷ KSTH Ãá°èÇмú´ëȸ : 2024-05-24 0 19 2024-05-10
20651 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚµÈ ÀÌ°ú Áúȯ : 2024-05-23 0 19 2024-05-10
20650 °æ±â Çϳ²½ÃÀÇ»çȸ¿¬¼ö°­ÁÂ(¸¸¼º±âħ, ºÒ¸éÁõ) : 2024-05-23 0 6 2024-05-10
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷